The eClinical solutions market is expected to be driven by growing demand for outsourcing drug development trials due to the varied proficiency of CROs as well as implementation of advanced healthcare solutions. Clinical trials play a major role during the development of new medical devices and drugs. Companies that undertake outsourced clinical trials perform extensive research and tasks, from preclinical trials to last stage development. Growing era of digitalization could pave the way for new advancements in the eClinical solutions industry.
Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/1774
According to a report published by Global Market Insights, the eClinical Solutions market size is expected to exceed USD 14.5 billion by 2027 is expected to reach a growth rate of 11.6% during the analysis timeframe. Although, heavy implementation and maintenance cost coupled with low adoption in developing countries could negatively impact industry expansion.
In terms of delivery mode, the eClinical solution market is divided into web-hosted (on-Demand) solutions, cloud-based (SAAS) solutions, and licensed enterprise (on-premise) solutions. The licensed enterprise (on-premises) solution segment is anticipated to show momentous growth of 10.8% during the analysis period. Licensed enterprise (on-premise) is a traditional software implementation mode in which end-users can purchase the software licensing based on their organizational requirements and can easily determine how it will be maintained and implemented in their premises.
With the growing need for process management tools and effective clinical data, the market is estimated to witness lucrative growth in the Asia Pacific region. The emergence of severe diseases, a huge patient population, and increasing clinical trials and R&D are some of the key factors driving regional market growth. Governments in the region are constantly funding for drug discovery and for conducting related research studies, factors that may lift the adoption of eClinical solutions and enhance market growth. As per a report, the Asia-Pacific eClinical solutions market is projected to demonstrate a CAGR of 12.9% during the forecast period.
Some of the major companies operating in the eClinical solutions market include Bioclinica, Merge Healthcare (IBM), Medidata, ALTEN Group (Aixial), Oracle Corporation, PAREXEL International, and Datatrak Int, among others. Industry players are focusing on new service launches and considering mergers and acquisitions to consolidate their market presence and for maintaining financial stability in the market. In 2019, Datatrak International, Inc. revealed the launch of EDC (electronic data capture) system to combine image storage, capture, display and adjudication through their Enterprise Cloud platform.
Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/eclinical-solutions-market
Partial Chapter of the Table of Content
Chapter 4 eClinical Solutions Market, By Solution
4.1 Key segment trends
4.2 Randomization & trial supply management (RTSM)
4.2.1 Market size, by region, 2016 - 2027 (USD Million)
4.3 Clinical data management system (CDMS)
4.3.1 Market size, by region, 2016 - 2027 (USD Million)
4.4 Clinical trial management system (CTMS)
4.4.1 Market size, by region, 2016 - 2027 (USD Million)
4.5 Electronic clinical outcome assessment (eCOA)
4.5.1 Market size, by region, 2016 - 2027 (USD Million)
4.6 Electronic trial master file (eTMF)
4.6.1 Market size, by region, 2016 - 2027 (USD Million)
4.7 Electronic data capture (EDC)
4.7.1 Market size, by region, 2016 - 2027 (USD Million)
4.8.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 5 eClinical Solutions Market, By Delivery Mode
5.1 Key segment trend
5.2 Licensed enterprise (on-premise) solution (LES)
5.2.1 Market size, by region, 2016 - 2027 (USD Million)
5.3 Cloud-based (SAAS) solution (CBS)
5.3.1 Market size, by region, 2016 - 2027 (USD Million)
5.4 Web-hosted (on-demand) solution (WHS)
5.4.1 Market size, by region, 2016 - 2027 (USD Million)